Teladoc Health Inc (NYSE:TDOC) price on Wednesday, December 04, rose 0.64% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.02.
A look at the stock’s price movement, the close in the last trading session was $10.95, moving within a range at $10.87 and $11.46. The beta value (5-Year monthly) was 0.9. Turning to its 52-week performance, $22.54 and $6.76 were the 52-week high and 52-week low respectively. Overall, TDOC moved 24.24% over the past month.
Teladoc Health Inc’s market cap currently stands at around $1.90 billion, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 639.92M for the company’s revenue for the quarter, with a low and high estimate of 628.76M and 673.75M respectively. The average forecast suggests down to a -3.12% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2.57B, representing a -1.30% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TDOC is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
19 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 10 analyst(s) rate the stock as a Hold, 9 recommend TDOC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TDOC’s current price about 8.20% and 16.30% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 58.36, while 7-day volatility ratio is 5.23% and 6.48% in the 30-day chart. Further, Teladoc Health Inc (TDOC) has a beta value of 0.98, and an average true range (ATR) of 0.69. Analysts have given the company’s stock an average 52-week price target of $12, forecast between a low of $9 and high of $20. Looking at the price targets, the low is 18.33% off current price level while to achieve the yearly target high, price needs to move -81.49%. Nonetheless, investors will most likely welcome a -8.89% jump to $12 which is the analysts’ median price.
If we refocus on Teladoc Health Inc (NYSE:TDOC), historical trading data shows that trading volumes averaged 6.6 over the past 10 days and 5.71 million over the past 3 months. The company’s latest data on shares outstanding shows there are 171.94 million shares.
The 2.12% of Teladoc Health Inc’s shares are in the hands of company insiders while institutional holders own 73.71% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 25.69 million on 2024-11-15, giving us a short ratio of 4.26. The data shows that as of 2024-11-15 short interest in Teladoc Health Inc (TDOC) stood at 1936.0 of shares outstanding, with shares short rising to 25.26 million registered in 2024-10-15. Current price change has pushed the stock -48.86% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TDOC stock continues to rise going into the next quarter.
